The United States Environmental Protection Agency (EPA) has announced a significant step in the battle against water pollution by proposing to classify microplastics and pharmaceuticals as contaminants in drinking water. This landmark decision, unveiled on 2 April 2026, signals a potential shift in regulatory standards and aims to address growing public concerns regarding the safety of drinking water supplies.
A New Era for Water Safety Regulations
In a move that aligns with the ongoing advocacy efforts of Robert F. Kennedy Jr.’s Maha movement, EPA Administrator Lee Zeldin highlighted the agency’s commitment to responding to citizens worried about contaminants in their water. The proposal seeks to add microplastics and pharmaceuticals to the EPA’s Contaminant Candidate List (CCL), which identifies harmful substances that are not currently regulated under the Safe Drinking Water Act. This draft list, now in its sixth iteration, will be open for public comment for 60 days, with a final version expected by mid-November.
Zeldin emphasised the urgency of this issue, stating, “I can’t think of an issue that hits closer to home for American families than the safety of their drinking water.” The announcement follows numerous studies demonstrating the prevalence of microplastics in various human organs and the potential health risks associated with pharmaceuticals that infiltrate water systems due to inadequate wastewater treatment.
Addressing the Contaminant Crisis
Research indicates that microplastics, tiny plastic particles less than five millimetres in size, have been detected in drinking water sources, as well as in human tissues. While health experts are still investigating the implications of these findings, the consensus is that there is significant cause for concern. Similarly, the presence of pharmaceuticals in the water supply—resulting from human excretion—poses additional challenges, as conventional treatment methods often fail to eliminate these substances.
The EPA’s CCL serves as a framework for prioritising research, funding, and regulatory actions. However, it is crucial to note that the agency has historically been slow to implement regulations on the pollutants listed, often leaving them unaddressed. Recent statements from the EPA suggest a reluctance to develop regulations for other contaminants previously examined, casting doubt on the effectiveness of the new proposal.
Advocacy Groups Respond
Environmental advocates have welcomed the proposal as a promising first step, but many stress the necessity for robust action beyond mere classification. Judith Enck, a former EPA regional administrator and current leader of Beyond Plastics, remarked, “Including it in the list would be the first step toward eventually regulating microplastics in public water supplies and hopefully this is not the last step.” However, Erik Olson, a senior attorney at the Natural Resources Defense Council, cautioned that this initiative might merely represent the beginning of a lengthy bureaucratic process that often yields little actionable change.
Dr. Philip Landrigan, director of the Global Observatory on Planetary Health at Boston College, echoed these sentiments, asserting that without curbing the escalating production of plastics, any regulatory measures may fall short of delivering meaningful impact. The United States is currently involved in international discussions aimed at addressing the global plastic pollution crisis, yet the country remains opposed to stringent limits on plastic manufacturing.
The advocacy group Food & Water Watch has also expressed reservations, arguing that while the listing is a crucial development, it lacks the necessary provisions for monitoring contaminants effectively. To this end, the EPA employs the Unregulated Contaminant Monitoring Rule, which gathers data on suspected pollutants in drinking water. The American Chemistry Council, representing industry interests, supports the idea of monitoring microplastics but insists that such efforts must adhere to standardised practices nationwide.
The Future of the Maha Agenda
The collaboration between the EPA and the Maha movement comes in response to a landscape where environmental priorities are often sidelined. Following a controversial executive order from Donald Trump aimed at bolstering glyphosate production, Kennedy expressed disappointment while stressing the importance of addressing agricultural stability and national security.
Kennedy’s independent presidential campaign for 2024 is heavily focused on combating plastic pollution, and he recently announced a $144 million initiative dubbed Systematic Targeting of Microplastics (STOMP). This programme aims to develop tools for detecting and quantifying microplastics, mapping their movement within the human body, and ultimately facilitating their removal. “We can’t treat what we cannot measure. We cannot regulate what we don’t understand,” Kennedy stated, asserting the need for comprehensive data to inform policy decisions.
Maha leaders, alongside farmers and organisations, have urged the EPA to tackle the health ramifications of pesticides and chemicals, calling for enhanced monitoring of microplastics and new exposure limits. David Murphy, a former fundraiser for Kennedy’s campaign, acknowledged the progress in addressing microplastics but expressed concerns about the EPA’s simultaneous approval of new pesticides, suggesting a contradictory approach.
Why it Matters
The EPA’s proposal to classify microplastics and pharmaceuticals as contaminants in drinking water marks a pivotal moment in the ongoing fight against environmental pollution. As public awareness grows around the implications of unsafe drinking water, this initiative could pave the way for more effective regulations that protect public health. However, the success of these efforts will ultimately depend on the agency’s commitment to follow through with robust monitoring and regulatory actions, ensuring that the safety of drinking water remains a top priority for future generations.
